Skyclarys Funding Crisis Rocks Ireland | Cork News

A controversial HSE decision not to fund the promising drug Skyclarys for Friedreich’s ataxia has sparked national outrage, especially after the tragic loss of Rory Coady and his brother Paudie’s ongoing struggle with the disease. Fianna Fáil junior minister Catherine Ardagh and others have publicly challenged the HSE’s stance, calling the reimbursement system broken and demanding action — as European neighbors like Germany, France, and Spain already cover the treatment. The letter sent to top government officials underscores a growing political firestorm over how Ireland prioritizes life-saving therapies for rare conditions, forcing a reckoning on what it means to truly support patients and families in crisis. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e4081f561ce73f4b